United Kingdom· GB-APID-12101411000001108
Increlex 40mg/4ml solution for injection vials
A mecasermin product containing mecasermin, registered in United Kingdom by Esteve Pharmaceuticals Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mecasermin is registered in 12 of 19 countries.
Countries holding a registration under ATC H01AC03 (mecasermin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Mecasermin · ATC H01AC03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mecasermin
- Manufacturer
- Esteve Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01AC03
- ATC class
- Mecasermin
- Defined daily dose
- 2 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 5
- gtin5036611000158
- gtin03582186001448
- gtin03582180002038
- gtin03582186006641
- gtin8431506001901
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for mecasermin.
Graded by severity as the source publishes them — 25 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mecasermin · interactions on record
25 records
- 25 moderate
Most severe, free to view
- Insulin (human)A10AB01moderate
- Insulin lisproA10AB04moderate
- Insulin aspartA10AB05moderate
- Insulin glulisineA10AB06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mecasermin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGUNA-IGFGuna spa
- CanadaINCRELEXIPSEN BIOPHARMACEUTICALS CANADA INC
- CzechiaINCRELEXEsteve Pharmaceuticals S.A., Barcelona
- SpainINCRELEX 10 mg/ml SOLUCION INYECTABLEEsteve Pharmaceuticals S.A.
- FinlandIncrelexEsteve Pharmaceuticals, S.A
- FranceINCRELEX 10 mg/ml, solution injectableESTEVE PHARMACEUTICALS (ESPAGNE)
- IrelandIncrelex 10 mg/ml solution for injectionEsteve Pharmaceuticals S.A.
- BelgiumIncrelex 10 mg/mlEsteve Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Increlex
- Liechtenstein · Increlex
- Norway · Increlex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ded71b5f-2fc2-4e04-b595-b88646839396 GET /v1/drugs/ded71b5f-2fc2-4e04-b595-b88646839396?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "12101411000001108",
"desc": "Increlex 40mg/4ml solution for injection vials (Esteve Pharmaceuticals Ltd)",
"form": "Solution for injection",
"vpid": "36041311000001102",
"source": "dmd",
"vtm_id": "776644005",
"strength": "10 mg",
"substance": "Mecasermin",
"ingredient": "Mecasermin",
"supplier_code": "3553701000001107"
}See everything about mecasermin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.